The Valley Desk

ArticleBiotechnology progressPublished

Rapid bioreactor process optimization and scale-up for production of a measles vector COVID-19 vaccine candidate

Read the publication ↗

Regional connection

Verified An author affiliation on the Europe PMC record names Merck & Co. Affiliation source

Institution
Merck & Co.

Publication record

Type
Article
Venue
Biotechnology progress
Published
Subject terms
Animals; Humans; Measles virus; Bioreactors; COVID-19; SARS-CoV-2; COVID-19 Vaccines; Microcarriers; Scale up; Measles; Vero; Covid‐19
PubMed ID
39912497
Added to directory
Source checked

Report a correction or request removal